Slow pathway elimination for atrioventricular nodal reentrant tachycardia with the 8-mm tip cryoablation catheter : an 18-month follow-up study

PURPOSE: The 9-French 8-mm tip cryoablation catheter confers a high rate of acute slow pathway (SP) elimination and an acceptable short-term outcome in patients with atrioventricular nodal reentrant tachycardia (AVNRT). The aim of this study was to investigate the long-term outcome of patients treated with this electrode in this indication.

METHODS: Eighty-two patients (female = 52) with a mean age of 54.9 ± 17.7 years underwent SP elimination for typical AVNRT with the 8-mm tip cryocatheter in our institution between November 2009 to June 2012. Clinical and procedural characteristics were prospectively collected.

RESULTS: Acute procedural success defined as AVNRT non-inducibility at the end of the procedure was obtained in 81/82 patients (98.7 %). Mean procedure duration and fluoroscopy time were 74.4 ± 28.7 min (range, 35-160 min) and 8.7 ± 5.3 min (range, 2-26 min), respectively. Mean number of energy applications was 4.0 ± 2.4 (range, 2-15). No permanent atrioventricular block was observed. Transient atrioventricular block occurred in 12 patients (14.6 %). Traumatic fast pathway conduction block occurred in one patient before cryoenergy delivery. Using an intention-to-treat analysis, 78 patients (95.1 %) remained free of AVNRT recurrence during a mean follow-up of 17.8 ± 9.3 months.

CONCLUSIONS: This study confirmed that the 8-mm tip cryocatheter is both safe and highly effective for SP conduction elimination in patients with AVNRT and demonstrated a low recurrence rate during a long-term follow-up.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing - 37(2013), 1 vom: 17. Juni, Seite 105-9

Sprache:

Englisch

Beteiligte Personen:

Peyrol, Michaël [VerfasserIn]
Sbragia, Pascal [VerfasserIn]
Uhry, Sabrina [VerfasserIn]
Boccara, Gilles [VerfasserIn]
Dolla, Eric [VerfasserIn]
Quatre, Amandine [VerfasserIn]
Guenoun, Maxime [VerfasserIn]
Lévy, Samuel [VerfasserIn]
Paganelli, Franck [VerfasserIn]

Links:

Volltext

Themen:

Clinical Trial
Journal Article

Anmerkungen:

Date Completed 07.01.2014

Date Revised 21.10.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s10840-012-9768-0

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM223511838